Kristen Backor is part of a group of academics and government and corporate employees that will discuss the development of survey measures around privacy.
For more information on this event, click here.
MFN is rewriting the launch planning playbook: Commercial and market access strategies must integrate to succeed
MFN-related uncertainty is reshaping pharmaceutical launch planning by making pricing, sequencing, and forecasting decisions more interconnected and...